Cargando…
The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906197/ https://www.ncbi.nlm.nih.gov/pubmed/36760255 http://dx.doi.org/10.21037/atm-22-5266 |
| _version_ | 1784883953859035136 |
|---|---|
| author | Avila, Jorge Leone, José Pablo |
| author_facet | Avila, Jorge Leone, José Pablo |
| author_sort | Avila, Jorge |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9906197 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99061972023-02-08 The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer Avila, Jorge Leone, José Pablo Ann Transl Med Editorial Commentary AME Publishing Company 2023-01-06 2023-01-15 /pmc/articles/PMC9906197/ /pubmed/36760255 http://dx.doi.org/10.21037/atm-22-5266 Text en 2023 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Avila, Jorge Leone, José Pablo The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer |
| title | The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer |
| title_full | The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer |
| title_fullStr | The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer |
| title_full_unstemmed | The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer |
| title_short | The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer |
| title_sort | role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906197/ https://www.ncbi.nlm.nih.gov/pubmed/36760255 http://dx.doi.org/10.21037/atm-22-5266 |
| work_keys_str_mv | AT avilajorge theroleofsacituzumabgovitecaninhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativemetastaticbreastcancer AT leonejosepablo theroleofsacituzumabgovitecaninhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativemetastaticbreastcancer AT avilajorge roleofsacituzumabgovitecaninhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativemetastaticbreastcancer AT leonejosepablo roleofsacituzumabgovitecaninhormonereceptorpositivehumanepidermalgrowthfactorreceptor2negativemetastaticbreastcancer |